You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Urological Cancer Therapeutics Drugs Market Analysis 2016-2020 and Forecast 2021-2026

Snapshot
The global Urological Cancer Therapeutics Drugs market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Urological Cancer Therapeutics Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Xofigo (radium Ra 223 dichloride)
Jevtana (cabazitaxel)
Inlyta (axitinib)
Votrient (pazopanib hydrochloride)
Sutent (sunitinib malate)
Zytiga (abiraterone acetate)
Xtandi (enzalutamide)
Opdivo (nivolumab)
Provenge (sipuleucel-T)
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Novartis
Pfizer
Johnson & Johnson
AstraZeneca
Astellas
Bristol-Myers Squibb
Abbott Laboratories
Celgene Corporation
Dendreon Corporation
Ferring Pharmaceuticals
GlaxoSmithKline plc
Indevus Pharmaceuticals Inc
Ipsen
Roche Healthcare
Sanofi S.A.
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospital
Medical Research Laboratory
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Urological Cancer Therapeutics Drugs Industry
Figure Urological Cancer Therapeutics Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Urological Cancer Therapeutics Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Urological Cancer Therapeutics Drugs
1.2.2 Downstream
Table Application Segment of Urological Cancer Therapeutics Drugs
Table Global Urological Cancer Therapeutics Drugs Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Urological Cancer Therapeutics Drugs Market by Type
3.1 By Type
3.1.1 Xofigo (radium Ra 223 dichloride)
Table Major Company List of Xofigo (radium Ra 223 dichloride)
3.1.2 Jevtana (cabazitaxel)
Table Major Company List of Jevtana (cabazitaxel)
3.1.3 Inlyta (axitinib)
Table Major Company List of Inlyta (axitinib)
3.1.4 Votrient (pazopanib hydrochloride)
Table Major Company List of Votrient (pazopanib hydrochloride)
3.1.5 Sutent (sunitinib malate)
Table Major Company List of Sutent (sunitinib malate)
3.1.6 Zytiga (abiraterone acetate)
Table Major Company List of Zytiga (abiraterone acetate)
3.1.7 Xtandi (enzalutamide)
Table Major Company List of Xtandi (enzalutamide)
3.1.8 Opdivo (nivolumab)
Table Major Company List of Opdivo (nivolumab)
3.1.9 Provenge (sipuleucel-T)
Table Major Company List of Provenge (sipuleucel-T)
3.2 Market Size
Table Global Urological Cancer Therapeutics Drugs Market 2016-2020, by Type, in USD Million
Figure Global Urological Cancer Therapeutics Drugs Market Growth 2016-2020, by Type, in USD Million
Table Global Urological Cancer Therapeutics Drugs Market 2016-2020, by Type, in Volume
Figure Global Urological Cancer Therapeutics Drugs Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Urological Cancer Therapeutics Drugs Market Forecast 2021-2026, by Type, in USD Million
Table Global Urological Cancer Therapeutics Drugs Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Novartis (Company Profile, Sales Data etc.)
4.1.1 Novartis Profile
Table Novartis Overview List
4.1.2 Novartis Products & Services
4.1.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Pfizer (Company Profile, Sales Data etc.)
4.2.1 Pfizer Profile
Table Pfizer Overview List
4.2.2 Pfizer Products & Services
4.2.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Johnson & Johnson (Company Profile, Sales Data etc.)
4.3.1 Johnson & Johnson Profile
Table Johnson & Johnson Overview List
4.3.2 Johnson & Johnson Products & Services
4.3.3 Johnson & Johnson Business Operation Conditions
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 AstraZeneca (Company Profile, Sales Data etc.)
4.4.1 AstraZeneca Profile
Table AstraZeneca Overview List
4.4.2 AstraZeneca Products & Services
4.4.3 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Astellas (Company Profile, Sales Data etc.)
4.5.1 Astellas Profile
Table Astellas Overview List
4.5.2 Astellas Products & Services
4.5.3 Astellas Business Operation Conditions
Table Business Operation of Astellas (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Bristol-Myers Squibb (Company Profile, Sales Data etc.)
4.6.1 Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Overview List
4.6.2 Bristol-Myers Squibb Products & Services
4.6.3 Bristol-Myers Squibb Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Abbott Laboratories (Company Profile, Sales Data etc.)
4.7.1 Abbott Laboratories Profile
Table Abbott Laboratories Overview List
4.7.2 Abbott Laboratories Products & Services
4.7.3 Abbott Laboratories Business Operation Conditions
Table Business Operation of Abbott Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Celgene Corporation (Company Profile, Sales Data etc.)
4.8.1 Celgene Corporation Profile
Table Celgene Corporation Overview List
4.8.2 Celgene Corporation Products & Services
4.8.3 Celgene Corporation Business Operation Conditions
Table Business Operation of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Dendreon Corporation (Company Profile, Sales Data etc.)
4.9.1 Dendreon Corporation Profile
Table Dendreon Corporation Overview List
4.9.2 Dendreon Corporation Products & Services
4.9.3 Dendreon Corporation Business Operation Conditions
Table Business Operation of Dendreon Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Ferring Pharmaceuticals (Company Profile, Sales Data etc.)
4.10.1 Ferring Pharmaceuticals Profile
Table Ferring Pharmaceuticals Overview List
4.10.2 Ferring Pharmaceuticals Products & Services
4.10.3 Ferring Pharmaceuticals Business Operation Conditions
Table Business Operation of Ferring Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 GlaxoSmithKline plc (Company Profile, Sales Data etc.)
4.11.1 GlaxoSmithKline plc Profile
Table GlaxoSmithKline plc Overview List
4.11.2 GlaxoSmithKline plc Products & Services
4.11.3 GlaxoSmithKline plc Business Operation Conditions
Table Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Indevus Pharmaceuticals Inc (Company Profile, Sales Data etc.)
4.12.1 Indevus Pharmaceuticals Inc Profile
Table Indevus Pharmaceuticals Inc Overview List
4.12.2 Indevus Pharmaceuticals Inc Products & Services
4.12.3 Indevus Pharmaceuticals Inc Business Operation Conditions
Table Business Operation of Indevus Pharmaceuticals Inc (Sales Revenue, Cost, Gross Margin)
4.13 Ipsen (Company Profile, Sales Data etc.)
4.13.1 Ipsen Profile
Table Ipsen Overview List
4.13.2 Ipsen Products & Services
4.13.3 Ipsen Business Operation Conditions
Table Business Operation of Ipsen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Roche Healthcare (Company Profile, Sales Data etc.)
4.14.1 Roche Healthcare Profile
Table Roche Healthcare Overview List
4.14.2 Roche Healthcare Products & Services
4.14.3 Roche Healthcare Business Operation Conditions
Table Business Operation of Roche Healthcare (Sales Revenue, Cost, Gross Margin)
4.15 Sanofi S.A. (Company Profile, Sales Data etc.)
4.15.1 Sanofi S.A. Profile
Table Sanofi S.A. Overview List
4.15.2 Sanofi S.A. Products & Services
4.15.3 Sanofi S.A. Business Operation Conditions
Table Business Operation of Sanofi S.A. (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Urological Cancer Therapeutics Drugs Sales Revenue 2016-2020, by Company, in USD Million
Table Global Urological Cancer Therapeutics Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Urological Cancer Therapeutics Drugs Sales Revenue Share in 2020, by Company, in USD Million
Table Global Urological Cancer Therapeutics Drugs Sales Volume 2016-2020, by Company, in Volume
Table Global Urological Cancer Therapeutics Drugs Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Urological Cancer Therapeutics Drugs Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Urological Cancer Therapeutics Drugs Market Concentration, in 2020
Figure Europe Urological Cancer Therapeutics Drugs Market Market Concentration, in 2020
Figure Asia-Pacific Urological Cancer Therapeutics Drugs MMarket Concentration, in 2020
Figure South America Urological Cancer Therapeutics Drugs Market Concentration, in 2020
Figure Middle East & Africa Urological Cancer Therapeutics Drugs Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital
Figure Urological Cancer Therapeutics Drugs Demand in Hospital, 2016-2020, in USD Million
Figure Urological Cancer Therapeutics Drugs Demand in Hospital, 2016-2020, in Volume
6.1.2 Demand in Medical Research Laboratory
Figure Urological Cancer Therapeutics Drugs Demand in Medical Research Laboratory, 2016-2020, in USD Million
Figure Urological Cancer Therapeutics Drugs Demand in Medical Research Laboratory, 2016-2020, in Volume
6.1.3 Demand in Others
Figure Urological Cancer Therapeutics Drugs Demand in Others, 2016-2020, in USD Million
Figure Urological Cancer Therapeutics Drugs Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Urological Cancer Therapeutics Drugs Demand Forecast 2021-2026, by Application, in USD Million
Figure Urological Cancer Therapeutics Drugs Market Growth 2021-2026, by Application, in USD Million
Figure Urological Cancer Therapeutics Drugs Market Share in 2026, by Application, in USD Million
Table Urological Cancer Therapeutics Drugs Demand Forecast 2021-2026, by Application, in Volume
Table Urological Cancer Therapeutics Drugs Market Growth 2021-2026, by Application, in Volume
Table Urological Cancer Therapeutics Drugs Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Urological Cancer Therapeutics Drugs Production 2016-2020, by Region, in USD Million
Table Urological Cancer Therapeutics Drugs Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Urological Cancer Therapeutics Drugs Market 2016-2020, by Region, in USD Million
Table Global Urological Cancer Therapeutics Drugs Market Share 2016-2020, by Region, in USD Million
Table Global Urological Cancer Therapeutics Drugs Market 2016-2020, by Region, in Volume
Table Global Urological Cancer Therapeutics Drugs Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Urological Cancer Therapeutics Drugs Market Size and Growth 2016-2020, in USD Million
Figure North America Urological Cancer Therapeutics Drugs Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Urological Cancer Therapeutics Drugs Market Size 2016-2020, by Country, in USD Million
Table North America Urological Cancer Therapeutics Drugs Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Urological Cancer Therapeutics Drugs Market Size and Growth 2016-2020, in USD Million
Figure Europe Urological Cancer Therapeutics Drugs Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Urological Cancer Therapeutics Drugs Market Size 2016-2020, by Country, in USD Million
Table Europe Urological Cancer Therapeutics Drugs Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Urological Cancer Therapeutics Drugs Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Urological Cancer Therapeutics Drugs Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Urological Cancer Therapeutics Drugs Market Size and Growth 2016-2020, in USD Million
Figure South America Urological Cancer Therapeutics Drugs Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Urological Cancer Therapeutics Drugs Market Size 2016-2020, by Country, in USD Million
Table South America Urological Cancer Therapeutics Drugs Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Urological Cancer Therapeutics Drugs Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Urological Cancer Therapeutics Drugs Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Urological Cancer Therapeutics Drugs Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Urological Cancer Therapeutics Drugs Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Urological Cancer Therapeutics Drugs Market Forecast 2021-2026, by Region, in USD Million
Table Urological Cancer Therapeutics Drugs Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
  • FORMAT: PDF
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 119